User profiles for Michael Buettcher

Michael Buettcher

Kinderspital Luzern, Paediatrische Infektiologie
Verified email at luks.ch
Cited by 3816

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study

…, H Schmid, F Zucol, A Niederer, M Buettcher… - The Lancet Child & …, 2020 - thelancet.com
Background To date, few data on paediatric COVID-19 have been published, and most reports
originate from China. This study aimed to capture key data on children and adolescents …

Three-year surveillance of intussusception in children in Switzerland

M Buettcher, G Baer, J Bonhoeffer, UB Schaad… - …, 2007 - publications.aap.org
OBJECTIVE. We attempted to obtain baseline data on the incidence of intussusception and
its association with gastroenteritis in a cross-sectional observational study in children. …

[HTML][HTML] Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (ProPAED): a randomized controlled trial

G Baer, P Baumann, M Buettcher, U Heininger… - PLoS …, 2013 - journals.plos.org
Background Antibiotics are overused in children and adolescents with lower respiratory tract
infection (LRTI). Serum-procalcitonin (PCT) can be used to guide treatment when bacterial …

[HTML][HTML] Swiss consensus recommendations on urinary tract infections in children

M Buettcher, J Trueck, A Niederer-Loher… - European journal of …, 2021 - Springer
The kidneys and the urinary tract are a common source of infection in children of all ages,
especially infants and young children. The main risk factors for sequelae after urinary tract …

[HTML][HTML] Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS …

…, G Blanchard-Rohner, M Buettcher… - The Lancet Child & …, 2023 - thelancet.com
Background The emergence of paediatric inflammatory multisystem syndrome temporally
associated with SARS-CoV-2 (PIMS-TS) led to the widespread use of anti-inflammatory …

[HTML][HTML] Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions

…, PKA Agyeman, C Aebi, M Buettcher… - The Lancet …, 2024 - thelancet.com
Mycoplasma pneumoniae is a common cause of respiratory tract infections with community-acquired
pneumonia as the major disease-related burden. Compared with other pathogens, …

Secukinumab therapy for Netherton syndrome

…, C Brunner, D Donghi, M Buettcher… - JAMA …, 2020 - jamanetwork.com
Importance Netherton syndrome (NS) is a rare, severe genetic disorder of cornification with
high morbidity. Treatment for NS has been notoriously difficult. Recent studies showed an …

Frequency and clinical presentation of mucocutaneous disease due to Mycoplasma pneumoniae infection in children with community-acquired pneumonia

PMM Sauteur, M Theiler, M Buettcher, M Seiler… - JAMA …, 2020 - jamanetwork.com
Importance The diagnosis ofMycoplasma pneumoniaeinfection as the cause of mucocutaneous
disease is challenging because current diagnostic tests are not able to differentiateM …

Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?

…, G Greub, PKA Agyeman, C Aebi, M Buettcher… - The Lancet …, 2022 - thelancet.com
… *Patrick M Meyer Sauteur, Victoria J Chalker, Christoph Berger, Ran Nir-Paz, Michael L
Beeton, on behalf of the ESGMAC and the ESGMAC–MyCOVID study group …

The development of standardized case definitions and guidelines for adverse events following immunization.

…, J Gidudu, J Bonhoeffer, MM Braun, M Buettcher… - Vaccine, 2007 - europepmc.org
International Conference on Harmonization. The medical dictionary for regulatory activities.
Available on the world wide web: http://www. ich. org/cache/compo/276-254-1. html and …